V. Boom

ORCID: 0000-0002-6127-596X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Immunodeficiency and Autoimmune Disorders
  • Chronic Disease Management Strategies
  • Healthcare Systems and Technology
  • Kawasaki Disease and Coronary Complications
  • Tracheal and airway disorders
  • Ocular Diseases and Behçet’s Syndrome
  • Infectious Diseases and Tuberculosis

University Medical Center Utrecht
2014-2020

St. Antonius Ziekenhuis
2018

Wilhelmina Children's Hospital
2013-2015

In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise disseminate diagnostic management regimens children young adults with rheumatic diseases. Juvenile idiopathic arthritis (JIA) is the most common disease uveitis possibly its devastating extra-articular manifestation. Evidence-based guidelines are sparse mostly based on physicians' experience. Consequently, treatment practices differ widely, within between...

10.1136/annrheumdis-2018-213131 article EN cc-by Annals of the Rheumatic Diseases 2018-03-28

Introduction eConsultation in nephrology is an innovative way for general practitioners (GPs) to consult a nephrologist. Studies have shown that questions from GPs can be answered and intended referrals avoided by eConsultation. However, follow-up data are lacking. The primary aim of this study was therefore assess whether patients whom referral the outpatient clinic medical specialist short term were not then referred same problem within one year after Methods All eConsultations sent...

10.1177/1357633x20942037 article EN Journal of Telemedicine and Telecare 2020-08-03

Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic pediatric rheumatic diseases (PRD). As case for PRD's, evidence-based guidelines are sparse and management based to great extent on physician’s experience. Moreover, there differences between nations regarding availability financing biological therapies. Consequently, treatment regimens differ throughout Europe. In 2012, a European initiative called SHARE (Single Hub Access point Rheumatology in Europe) was launched...

10.1186/1546-0096-12-s1-p171 article EN cc-by Pediatric Rheumatology 2014-09-01

Pediatric Rheumatic Diseases (PRD) represent a group of rare diseases that can lead to significant morbidity. As is the problem with many diseases, evidence-based guidelines are lacking and treatment mostly based on physician experience. Consequently, regiments differ throughout Europe. This year, new project called SHARE (Single Hub Access point for pediatric Rheumatology in Europe) was launched describe what needed optimal diagnosis children young adults rheumatic disease. tackles problems...

10.1186/1546-0096-11-s2-p12 article EN cc-by Pediatric Rheumatology 2013-12-01
Coming Soon ...